News from the debiopharm group A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 15, 2012, 03:00 ET

Debiopharm and Vifor Pharma Sign an Exclusive Agreement for the Distribution and Commercialization of Pamorelin®LA in Switzerland - A Drug Treatment for Prostate Cancer and Endometriosis

Debiopharm Group™ (Debiopharm) and Vifor Pharma announce the signing of an exclusive agreement covering the distribution and...

Feb 16, 2012, 07:00 ET

Debiopharm and Curis Announce Initiation of Phase Ib Expansion Study of HSP90 Inhibitor Debio 0932

Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop proprietary targeted medicines for cancer treatment, and Debiopharm...

Nov 09, 2011, 05:07 ET

Augurix Diagnostics Receives the 2011 'Debiopharm /Valais Award' for its Point-of-care Diagnostic Test for the Early Detection of Celiac Disease

Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group with a focus on drug development and companion diagnostics,...

Oct 05, 2011, 04:00 ET

The Japanese Cancer Association and Debiopharm Group™ Present Doctors Arakawa and Kurokawa With the 2011 'JCA-Mauvernay Award' for Their Innovative and Outstanding Research in the Field of Cancer

Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group with a focus on drug development and companion diagnostics,...

Sep 08, 2011, 04:00 ET

Debiopharm Group™ Presents the 'Debiopharm Group™ Life Sciences Award 2011' and two 'Junior Debiopharm Group™ Awards 2011' at the ISREC 2011 Life Sciences Symposium

Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group with a focus on drug development and companion diagnostics,...

Jul 26, 2011, 03:00 ET

INC Research and Debiopharm Group(TM) Announce Strategic Partnership

INC Research, LLC, a therapeutically focused contract research organisation (CRO) with a trusted process for delivering reliable results, and...

Jul 14, 2011, 04:45 ET

Continuity as Debiopharm Group™ Management Moves Forward

  Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of...

May 04, 2011, 03:00 ET

Debiopharm and Yale Announce an Exclusive License Agreement for the Development and Commercialization of Debio 1036, a First-in-Class Inhibitor for Autoimmune and Inflammatory Diseases

Debiopharm Group(TM) (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly...

Apr 14, 2011, 03:00 ET

Debiopharm and Aurigene Sign Agreement for the Development and Commercialisation of Debio 1142, a Novel Inhibitor of an Undisclosed Oncology Pathway

LAUSANNE, Switzerland and BANGALORE, India, April 14, 2011 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a global biopharmaceutical...

Jan 18, 2011, 03:00 ET

Diagnoplex Closes an Extension of its Series A Financing With a Substantial Investment by Debiopharm Group(TM)

Diagnoplex SA, a developer of molecular diagnostics for colon cancer and Debiopharm Group(TM) announced today that Diagnoplex has closed a series A...

Dec 01, 2010, 10:00 ET

Frost & Sullivan Presents Debiopharm Group(TM) with "European Biopharmaceuticals Company of the Year Award"

Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative...

Nov 23, 2010, 09:00 ET

Abionic Wins the 'Prix Debiopharm Valais Pour les Sciences de la Vie' for its Innovative Biomedical Device for Diagnostic Testing

Debiopharm Group(TM) (Debiopharm), an independent specialist in global bio-pharmaceutical development in the field of oncology and regarding...

Sep 24, 2010, 02:59 ET

The Japanese Cancer Association and Debiopharm Group(TM) Present the JCA-Mauvernay Award to Dr Ogawa and Prof. Maeda for Their Outstanding Oncology Research

Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative...

Sep 13, 2010, 03:00 ET

Debiopharm Group™ and Aurigene Nominate Development Candidate

Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative...

Sep 02, 2010, 12:10 ET

Professor Leroux From ETH Receives the Debiopharm Life Sciences Award 2010

Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative...

Apr 27, 2010, 07:59 ET

Debiopharm Group(TM) Starts Phase I Clinical Trial With Debio 0932

Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative...

Apr 08, 2010, 03:00 ET

Debiopharm Group(TM) and Biocartis Embark on a Partnership Aiming at Enhancing Personalized Medicine

Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative...

Feb 09, 2010, 03:30 ET

Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025

Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that...

Feb 04, 2010, 01:30 ET

Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer

Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical group and Debiopharm Group (Debiopharm), a Swiss-based...